6076 Persistence20Market20Research 29

The Hyperthermia Treatment For Cancer Market will reach US$ 160 Million at a CAGR of 6.1% between 2025. Analytics and big data process unstructured as well as the structured biomedical structure and medical data for generating new-fangled insights. As such, digital therapy experiences get an enhanced look with MR (mixed reality), AR (augmented reality), and VR (virtual reality). This would be the trend regarding the healthcare vertical in the forecast period.

The increasing number of cancer patient worldwide is translating into higher demand for cancer therapies. Governments in various countries have launched promotional campaigns to aware people about getting the right cancer treatment.

To an extent, these aforementioned factors are helping popularize various cancer therapeutics including hyperthermia treatment for cancer. Moreover, medical institutes are working in collaboration with the government for cancer research to further improve diagnosis and treatment.

Get Going With Sample Of Hyperthermia Treatment For Cancer Market Report! https://www.persistencemarketresearch.co/samples/14632

Company Profiles 

  • Celsius42+ GmbH
  • Pyrexar Medical Inc.
  • Oncothermia
  • Hydrosun GmbH
  • Yamamoto Vinita Co., Ltd
  • Andromedic Srl
  • Haifu Medical Technology Co. Ltd

How About Re-Inventing The Methodical Wheel In The Hyperthermia Treatment For Cancer Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.co/methodology/14632

Clinical trials are also funded by governments to support companies in developing effective hyperthermia treatment for cancer. Persistence Market Research (PMR) in its latest report titled “Hyperthermia Treatment for Cancer Market: Global Industry Analysis and Forecast, 2017–2025” projects that global hyperthermia treatment for cancer market revenue will surge at a CAGR of 6.1% during the forecast period (2017–2025).

Global Hyperthermia Treatment for Cancer Market – Key Highlights 

There is a growing awareness regarding the therapeutic effect of hyperthermia on various types of malignant diseases and this in turn is likely to increase the revenue growth of the global hyperthermia devices market. The increasing number of experts in the field of hyperthermia are creating awareness among patients regarding the use of hyperthermia to destroy tumor cells and to increase drug absorption in the target cells by using hyperthermia treatment in combination with chemotherapy.

By device type, the microwave hyperthermia device segment is estimated to account for 41.4% revenue share of the market by 2017-end. The segment is expected to further gain traction, owing to its ability to transmit energy from antenna to cancer cells without getting stuck in fat layers. Meanwhile, short-wave hyperthermia device segment is expected to witness the fastest CAGR of 7.0% during the forecast period.

Keeping A Tab On Key Players In The Hyperthermia Treatment For Cancer Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Hyperthermia Treatment For Cancer Market Report! https://www.persistencemarketresearch.com/checkout/14632

Based on application, breast cancer and leukemia segments collectively accounted for 45% of the total market in 2016 and is expected to remain as the two dominant application segments of the market in 2017 and beyond.

By end use, the hospitals end user segment accounted for more than 42% share of the market. This is primarily owing to the growing ration of cancer patients in hospitals.

Among regions, the market for hyperthermia treatment for cancer in North America is expected to remain dominant throughout the forecast. In 2016, the region’s market reached a valuation of US$ 39.4 Mn and anticipated to grow at a CAGR of 5.5% over the projection period.

This is majorly attributed to the presence of leading medical companies and healthcare organizations in the region. Meanwhile, the market in Asia-Pacific is set to witness the fastest CAGR of 7.2%. By the 2017-end, the region is projected to account for 10.0% revenue share of the market.

Access Trending Reports:

Holter Monitoring Systems Market – Holter monitoring systems are proving to be more efficient in ECG monitoring due to advancements in technology, thereby allowing healthcare providers to monitor recorded data remotely, and enhancements in holter monitoring software, which enable better analysis of data. These factors are expected to promote the global holter monitoring systems market at a CAGR of 4.5% from2021to2031.

Aneurysm Clips Market – PMR forecasts indicate a steady growth in revenue in the global aneurysm clips market at a sluggish rate of 1.7% during 2018–2028. Global revenue is slated to reach US$ 21.5 Mn by the end of 2018.

Cervical Total Disc Replacement Market – As per PMR analysis, the cervical total disc replacement device market is set to expand at an impressive CAGR of 19% from 2020 to 2030, and reach a market valuation of US$ 9.3 Bn by 2030-end.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Website – https://www.persistencemarketresearch.com

Tags: Hyperthermia Treatment for Cancer Market Growth, Hyperthermia Treatment for Cancer market forecast, Hyperthermia Treatment for Cancer market analysis, Hyperthermia Treatment For Cancer Market Valuation, Global Study On Hyperthermia Treatment For Cancer Market

See Campaign: https://www.persistencemarketresearch.com/market-research/hyperthermia-treatment-for-cancer-market.a
Contact Information:
Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353

PR-Wirein, Menafn, Reportedtimes, iCN Internal Distribution, Extended Distribution, Research Newswire, English